Chinese Journal of Pharmaceuticals, Volume. 56, Issue 7, 863(2025)

Optimized Synthetic Process of Mivacurium Chloride

GUO Shuqian1, ZHU Shiguo2, SUN Xiaolei2, ZHANG Naihua2, and ZHANG Guimin1,2、*
Author Affiliations
  • 1School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355
  • 2National Engineering and Technology Research Center of Chirality Pharmaceutical, Lunan Pharmaceutical Group Co., Ltd., Linyi 273400
  • show less

    A synthetic process of mivacurium chloride (1) was optimized. 3, 4, 5-Trimethoxyphenylacetic acid (7) and 3, 4-dimethoxyphenylethylamine were used as starting materials to obtain the key intermediate (R)-5'-methoxylabdanin[(R) -2] dibenzoyl tartrate through dehydration condensation, intramolecular cyclization, imine reduction, reductive amination, and chiral resolution. Compound (R) -2 dibenzoyl tartrate reacted with 1, 3-propylene glycol cyclic sulfate under alkaline conditions via nucleophilic substitution and hydrolysis to obtain its quaternary ammonium alcohol (3). Finally, compound 3 was condensed with trans-4-octene-1, 8-dicarboxylic acid to obtain 1. In the post-treatment of the intramolecular cyclization step, omission of alkaline solution for quenching phosphorus oxychloride effectively prevented the formation of oxidative impurities. The synthesis of (R) -2 dibenzoyl tartrate was improved by reducing two resolutions to a single step, increasing the resolution yield from 33% to 42%. Replacing 3-chloropropanol with 1, 3-propylene glycol cyclic sulfate during the synthesis of compound 3 eliminated polymer impurity A and simplified the process by omitting column chromatography. The optimized process achieved a total yield of 17.0% (based on 7), and a purity of 99.6%. It was verified by kilogram-level amplification and was suitable for industrial production.

    Tools

    Get Citation

    Copy Citation Text

    GUO Shuqian, ZHU Shiguo, SUN Xiaolei, ZHANG Naihua, ZHANG Guimin. Optimized Synthetic Process of Mivacurium Chloride[J]. Chinese Journal of Pharmaceuticals, 2025, 56(7): 863

    Download Citation

    EndNote(RIS)BibTexPlain Text
    Save article for my favorites
    Paper Information

    Category:

    Received: Dec. 31, 2024

    Accepted: Aug. 26, 2025

    Published Online: Aug. 26, 2025

    The Author Email: ZHANG Guimin (lunanzhangguimin@163.com)

    DOI:10.16522/j.cnki.cjph.2025.07.004

    Topics